Eaton Vance Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-115
Closed -$5K – 2905
2021
Q1
$5K Buy
+115
New +$5.57K ﹤0.01% 2592

Other funds holding HCAT

Eaton Vance Management's HCAT Position: Q2 2021 in Review

Eaton Vance Management sold out of Health Catalyst (HCAT) in Q2 2021, closing a stake of 115 shares — an estimated $5K sold.

Eaton Vance Management first reported a position in HCAT in Q1 2021 and held it in 1 quarter. The position peaked at $5K in Q1 2021. 198 funds tracked by Wall St. Rank hold HCAT as of Q2 2021.

  • Eaton Vance Management reported no remaining Health Catalyst position as of Q2 2021 after selling out during the quarter.
  • Eaton Vance Management sold 115 Health Catalyst shares in Q2 2021, an estimated $5K.
  • Eaton Vance Management first reported a position in Health Catalyst in Q1 2021 and held it in 1 quarter.
  • Eaton Vance Management's Health Catalyst position peaked at $5K in Q1 2021.
  • 198 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2021.

Based on Eaton Vance Management's 13F filing for Q2 2021, filed 16 Aug 2021.